Vimarsana
Biggest News Aggregation in the World

Page 3 - Daniel Gooch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Gooch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Gooch Today - Breaking & Trending Today

BC Platforms appoints Dr Carolin Bender as Chief Medical - Vimarsana News

BC Platforms appoints Dr Carolin Bender as Chief Medical

ZURICH, Switzerland, April 03, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces...

TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials - Vimarsana News

TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials

TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces the final close of its EUR 22 million (approximately USD 23.8 million) round. This follows

BC Platforms Selected as Partner to Deliver key Singapore Population Health Study - Vimarsana News

BC Platforms Selected as Partner to Deliver key Singapore Population Health Study

BC Platforms Selected as Partner to Deliver key Singapore Population Health Study First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases GlobeNewswire January 09, 2023 ZURICH, Switzerland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today...

BC Platforms Announces Powerful Patient Data Sharing Platform to speed up Biotech R&D Process - Vimarsana News

BC Platforms Announces Powerful Patient Data Sharing Platform to speed up Biotech R&D Process

BCP's 'Trusted Collaboration Environment (TCE)' is a research infrastructure service and software solution that supports development of novel therapies using industry leading healthcare data

EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics - Vimarsana News

EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics

/PRNewswire/ -- EnteroBiotix Limited, the premier full-spectrum microbiome therapeutics company, today announced that it has been granted a Manufacturer's...